Cargando…

Genome profiling revealed the activation of IL2RG/JAK3/STAT5 in peripheral T-cell lymphoma expressing the ITK-SYK fusion gene

Peripheral T-cell lymphomas (PTCLs) are heterogeneous malignancies that are types of non-Hodgkin lymphomas; patients with this disease have poor prognoses. The IL-2-inducible T-cell kinase-spleen tyrosine kinase (ITK-SYK) fusion gene, the first recurrent chromosome translocation in PTCL-not otherwis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Lei-Lei, Pan, Hua-Xiong, Wang, Yi-Xuan, Guo, Tao, Liu, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776186/ https://www.ncbi.nlm.nih.gov/pubmed/31545408 http://dx.doi.org/10.3892/ijo.2019.4882

Ejemplares similares

The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma
por: Pechloff, Konstanze, et al.
Publicado: (2010)

Okadaic Acid Activates JAK/STAT Signaling to Affect Xenobiotic Metabolism in HepaRG Cells
por: Wuerger, Leonie T. D., et al.
Publicado: (2023)

MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma
por: Ramis-Zaldivar, Joan Enric, et al.
Publicado: (2021)

Role of TGM2 in T-cell lymphoblastic lymphoma via regulation of IL-6/JAK/STAT3 signalling
por: Wang, Yuyan, et al.
Publicado: (2022)

Simultaneous inhibition of JAK and SYK kinases ameliorates chronic and destructive arthritis in mice
por: Llop-Guevara, Alba, et al.
Publicado: (2015)

The roles of JAK2/STAT3 signaling in fusion of the secondary palate
por: Yoshida, Naoki, et al.
Publicado: (2023)

JAKs and STATs in chemoresistance
por: Costa-Pereira, Ana P
Publicado: (2010)

JAK-STAT and feeding
por: Ladyman, Sharon R., et al.
Publicado: (2013)

JAK/STAT PATHWAY COOPERATES WITH CIC FUSIONS TO DRIVE CIC-REARRANGED SARCOMAS
por: Kaloti, R K, et al.
Publicado: (2023)

Role of IL-6/JAK/STAT pathway in inducing vascular insulin resistance
por: Balakrishnan, Aswath, et al.
Publicado: (2014)

Proinflammatory Cytokine IL-6 and JAK-STAT Signaling Pathway in Myeloproliferative Neoplasms
por: Čokić, Vladan P., et al.
Publicado: (2015)

Robustness and Information Transfer within IL-6-induced JAK/STAT Signalling
por: Billing, Ulrike, et al.
Publicado: (2019)

Oncogenic Cooperation Between IL7R-JAK-STAT Pathway Mutations
por: Lodewijckx, Inge, et al.
Publicado: (2021)

The role of IL-6/JAK2/STAT3 signaling pathway in cancers
por: Huang, Bei, et al.
Publicado: (2022)

Analysis of the Influence of IL-6 and the Activation of the Jak/Stat3 Pathway in Fibromyalgia
por: Marino, Ylenia, et al.
Publicado: (2023)

The role of IL‐6/JAK/STAT signal in female infertility caused by hydrosalpinx
por: Deng, Jia, et al.
Publicado: (2023)

HSP90 is essential for Jak-STAT signaling in classical Hodgkin lymphoma cells
por: Schoof, Nils, et al.
Publicado: (2009)

Mutations in the JAK/STAT and RAS signaling pathways are common in Intestinal T-cell Lymphomas
por: Nicolae, Alina, et al.
Publicado: (2016)

Zhike pingchuan granules improve bronchial asthma by regulating the IL-6/JAK2/STAT3 pathway
por: Ren, Yumei, et al.
Publicado: (2021)

A Fusion Cytokine Coupling GMCSF to IL9 Induces Heterologous Receptor Clustering and STAT1 Hyperactivation through JAK2 Promiscuity
por: Li, Pingxin, et al.
Publicado: (2013)

Renoprotective Effect of the Recombinant Anti-IL-6R Fusion Proteins by Inhibiting JAK2/STAT3 Signaling Pathway in Diabetic Nephropathy
por: Zhang, Nanwen, et al.
Publicado: (2021)

Icaritin suppresses multiple myeloma, by inhibiting IL-6/JAK2/STAT3
por: Zhu, Shicong, et al.
Publicado: (2015)

IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment
por: Manore, Sara G., et al.
Publicado: (2022)

A JAK/STAT invasion
por: Wells, William A.
Publicado: (2002)

JAK-STAT and bone metabolism
por: Li, Jiliang
Publicado: (2013)

The Drosophila JAK-STAT pathway
por: Zeidler, Martin P, et al.
Publicado: (2013)

Evolution of the JAK-STAT pathway
por: Liongue, Clifford, et al.
Publicado: (2013)

The JAK-STAT pathway at 20
por: Darnell, Jr., James E.
Publicado: (2012)

JAK-STAT in lymphoproliferative disorders
por: Rabadan, Raul, et al.
Publicado: (2015)

IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma
por: Gu, Fang-Ming, et al.
Publicado: (2011)

Favorable prognostic role of IL-26 in HCC patients associated with JAK-STAT3-dependent autophagy
por: Zhao, Qihong, et al.
Publicado: (2021)

RBMS1 promotes gastric cancer metastasis through autocrine IL-6/JAK2/STAT3 signaling
por: Liu, Mengyuan, et al.
Publicado: (2022)

Inhibition of IL-6/JAK/STAT3 pathway rescues denervation-induced skeletal muscle atrophy
por: Huang, Ziwei, et al.
Publicado: (2020)

An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
por: Lensing, Maddison, et al.
Publicado: (2022)

Associations of potentially functional variants in IL-6, JAKs and STAT3 with gastric cancer risk in an eastern Chinese population
por: Zhou, Fei, et al.
Publicado: (2016)

A novel orally available Syk/Src/Jak2 inhibitor, SKLB-850, showed potent anti-tumor activities in B cell lymphoma (BCL) models
por: Zhang, Nannan, et al.
Publicado: (2017)

Intracellular expression of IRF9 Stat fusion protein overcomes the defective Jak-Stat signaling and inhibits HCV RNA replication
por: Poat, Bret, et al.
Publicado: (2010)

FUS-DDIT3 Fusion Oncoprotein Expression Affects JAK-STAT Signaling in Myxoid Liposarcoma
por: Dolatabadi, Soheila, et al.
Publicado: (2022)

IL-13RA2 downregulation in fibroblasts promotes keloid fibrosis via JAK/STAT6 activation
por: Chao, Hua, et al.
Publicado: (2023)

Inhibition of tumour necrosis factor and IL-17 production by leflunomide involves the JAK/STAT pathway
por: González-Alvaro, I, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_statj4555alg2585blpg59liu0